HK69992A - Manufacture of tetra-alkyl ethenylidene bis phosphonates and use thereof in pharmaceutical compositions - Google Patents

Manufacture of tetra-alkyl ethenylidene bis phosphonates and use thereof in pharmaceutical compositions

Info

Publication number
HK69992A
HK69992A HK699/92A HK69992A HK69992A HK 69992 A HK69992 A HK 69992A HK 699/92 A HK699/92 A HK 699/92A HK 69992 A HK69992 A HK 69992A HK 69992 A HK69992 A HK 69992A
Authority
HK
Hong Kong
Prior art keywords
tetra
manufacture
pharmaceutical compositions
alkyl
phosphonates
Prior art date
Application number
HK699/92A
Other languages
English (en)
Inventor
Charles Raymond Degenhardt
Duane Larry Charbonneau
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of HK69992A publication Critical patent/HK69992A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4025Esters of poly(thio)phosphonic acids
    • C07F9/4028Esters of poly(thio)phosphonic acids containing no further substituents than -PO3H2 groups in free or esterified form
    • C07F9/4031Acyclic unsaturated derivatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Detergent Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
HK699/92A 1985-11-04 1992-09-17 Manufacture of tetra-alkyl ethenylidene bis phosphonates and use thereof in pharmaceutical compositions HK69992A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US79530685A 1985-11-04 1985-11-04
US06/855,877 US4820698A (en) 1985-11-04 1986-04-23 Antimicrobial agents and process for their manufacture

Publications (1)

Publication Number Publication Date
HK69992A true HK69992A (en) 1992-09-25

Family

ID=27121606

Family Applications (1)

Application Number Title Priority Date Filing Date
HK699/92A HK69992A (en) 1985-11-04 1992-09-17 Manufacture of tetra-alkyl ethenylidene bis phosphonates and use thereof in pharmaceutical compositions

Country Status (16)

Country Link
US (1) US4820698A (da)
EP (1) EP0221611A3 (da)
JP (2) JP2525379B2 (da)
KR (1) KR950005876B1 (da)
AU (1) AU607685B2 (da)
CA (1) CA1291765C (da)
DK (1) DK167809B1 (da)
EG (1) EG18789A (da)
FI (1) FI864462A (da)
GB (1) GB2183652B (da)
HK (1) HK69992A (da)
IL (1) IL80480A (da)
NO (1) NO864378L (da)
NZ (1) NZ218149A (da)
PH (1) PH24524A (da)
SG (1) SG76092G (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5089266A (en) * 1989-10-10 1992-02-18 Merlin Lee Non-toxic insecticide composition and method for killing specific insects
FI92465C (fi) * 1993-04-14 1994-11-25 Risto Tapani Lehtinen Menetelmä endo-osteaalisten materiaalien käsittelemiseksi
US5854227A (en) * 1994-03-04 1998-12-29 Hartmann; John F. Therapeutic derivatives of diphosphonates
DE19615812A1 (de) * 1996-04-20 1997-10-23 Boehringer Mannheim Gmbh Pharmazeutische Zubereitung enthaltend Diphosphonsäuren zur oralen Applikation
US6210695B1 (en) 1997-06-04 2001-04-03 The Procter & Gamble Company Leave-on antimicrobial compositions
US5968539A (en) * 1997-06-04 1999-10-19 Procter & Gamble Company Mild, rinse-off antimicrobial liquid cleansing compositions which provide residual benefit versus gram negative bacteria
US6287577B1 (en) 1997-11-12 2001-09-11 The Procter & Gamble Company Leave-on antimicrobial compositions which provide improved residual benefit versus gram positive bacteria
US6190675B1 (en) 1997-06-04 2001-02-20 Procter & Gamble Company Mild, rinse-off antimicrobial liquid cleansing compositions which provide improved residual benefit versus gram positive bacteria
US6214363B1 (en) 1997-11-12 2001-04-10 The Procter & Gamble Company Liquid antimicrobial cleansing compositions which provide residual benefit versus gram negative bacteria
US6197315B1 (en) 1997-06-04 2001-03-06 Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus gram negative bacteria
US6183763B1 (en) 1997-06-04 2001-02-06 Procter & Gamble Company Antimicrobial wipes which provide improved immediate germ reduction
US6190674B1 (en) 1997-06-04 2001-02-20 Procter & Gamble Company Liquid antimicrobial cleansing compositions
US6284259B1 (en) 1997-11-12 2001-09-04 The Procter & Gamble Company Antimicrobial wipes which provide improved residual benefit versus Gram positive bacteria
US6183757B1 (en) 1997-06-04 2001-02-06 Procter & Gamble Company Mild, rinse-off antimicrobial cleansing compositions which provide improved immediate germ reduction during washing
US6099853A (en) * 1997-09-04 2000-08-08 Protein Express Vaginal suppository vaccine for urogenital infections
US7135191B2 (en) * 1997-09-04 2006-11-14 Zsolt Istvan Hertelendy Urogenital or anorectal transmucosal vaccine delivery system
US6287583B1 (en) 1997-11-12 2001-09-11 The Procter & Gamble Company Low-pH, acid-containing personal care compositions which exhibit reduced sting
AU754862B2 (en) 1998-12-23 2002-11-28 Bioagency Ag Use of bisphosphonates for the prevention and treatment of infectious processes
DE19902924A1 (de) * 1999-01-26 2000-08-03 Hassan Jomaa Verwendung von phosphororganischen Verbindungen zur prophylaktischen und therapeutischen Behandlung von Infektionen
EP1956903B1 (en) * 2005-11-29 2017-01-11 Ambria Dermatology AB Use of an absorption product comprising pentane-1, 5-diol as deodorant
US20090111736A1 (en) * 2007-10-29 2009-04-30 Sri International Orally-Absorbed Solid Dose Formulation for Vancomycin
US8222192B2 (en) * 2009-06-19 2012-07-17 R&W Medical LLC Alcohol-based skin cleanser
EP2750711A2 (en) * 2011-08-31 2014-07-09 Mallinckrodt LLC Remote assembly of targeted nanoparticles using h-phosphonate-ene/-yne hydrophosphonylation reactions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3062792A (en) * 1960-03-01 1962-11-06 Eastman Kodak Co Polymers derived from tetraalkyl vinylidenediphosphonates
DE1225818B (de) * 1964-03-18 1966-09-29 Monsanto Co Verwendung wasserloeslicher Polyphosphonsaeure-verbindungen als Potenzierungsmittel fuer Bakterizide
US3544509A (en) * 1967-05-08 1970-12-01 Monsanto Co Diphosphonic acids and salts thereof as flame retardants
GB1204967A (en) * 1967-05-08 1970-09-09 Monsanto Co Organic phosphorus compounds, their production and use
US3576793A (en) * 1967-05-08 1971-04-27 Monsanto Co Polymers of alkylene diphosphonic acids and salts and copolymers thereof
US3657282A (en) 1969-01-23 1972-04-18 Merck & Co Inc Carboxyepoxyethyl-1-phosphonic acid and derivatives

Also Published As

Publication number Publication date
DK167809B1 (da) 1993-12-20
EG18789A (en) 1995-07-27
NO864378D0 (no) 1986-11-03
EP0221611A3 (en) 1988-01-27
GB2183652B (en) 1989-10-18
CA1291765C (en) 1991-11-05
JPH08104634A (ja) 1996-04-23
DK526586D0 (da) 1986-11-04
FI864462A (fi) 1987-05-05
IL80480A (en) 1991-12-12
IL80480A0 (en) 1987-02-27
US4820698A (en) 1989-04-11
FI864462A0 (fi) 1986-11-03
NO864378L (no) 1987-05-05
NZ218149A (en) 1990-03-27
KR870004997A (ko) 1987-06-04
EP0221611A2 (en) 1987-05-13
JPS62167790A (ja) 1987-07-24
AU6467986A (en) 1987-05-07
DK526586A (da) 1987-05-05
JP2541794B2 (ja) 1996-10-09
PH24524A (en) 1990-07-18
GB2183652A (en) 1987-06-10
AU607685B2 (en) 1991-03-14
JP2525379B2 (ja) 1996-08-21
KR950005876B1 (ko) 1995-06-02
SG76092G (en) 1992-10-02
GB8626240D0 (en) 1986-12-03

Similar Documents

Publication Publication Date Title
HK69992A (en) Manufacture of tetra-alkyl ethenylidene bis phosphonates and use thereof in pharmaceutical compositions
GR861825B (en) Complexes of flavanolignanes with phospholipids preparation thereof and associated pharmaceutical compositions
IL74758A0 (en) Acyltripeptides and pharmaceutical compositions containing them
GR861601B (en) Thiazoles their production and pharmaceutical compositions containing them
NZ211145A (en) 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
NZ216918A (en) Pyridazines and pharmaceutical compositions
NZ216793A (en) Phenethanolaminotetraline derivatives and pharmaceutical compositions
IL82221A0 (en) Phenyl-piperazines and pharmaceutical compositions containing them
NZ212005A (en) Pyrrolobenzimidazoles and pharmaceutical compositions
IL88433A0 (en) Diarylstyrylquinoline diacids and pharmaceutical compositions containing them
IL78980A0 (en) Nasal pharmaceutical compositions and their production
NZ218749A (en) 5 to 8-membered azacyclic derivatives and pharmaceutical compositions
IL79376A (en) Substituted di-t-butylphenols and pharmaceutical compositions containing them
IL82146A0 (en) Liposomes based on phosphatidyl-inositolmannosides and pharmaceutical compositions containing them
IL79525A (en) Phenylpiperazine phosphonates and pharmaceutical compositions containing them
NZ214821A (en) Spiro-dioxolanes, -dithiolanes and -oxothiolanes and pharmaceutical compositions
NZ217798A (en) N-substituted diphenylpiperidines and pharmaceutical compositions
NZ217078A (en) N-piperidyl-benzamide derivatives and pharmaceutical compositions
NZ212953A (en) 3-acyl-1-aminoalkyl-1h-indoles and pharmaceutical compositions thereof
NZ215070A (en) Imidazole-indoles and pharmaceutical compositions
NZ216720A (en) Diazinylpiperidine derivatives and pharmaceutical compositions
NZ216546A (en) Glycerol derivatives and pharmaceutical compositions
IL79003A0 (en) Tetrahydroimidazoquinazolinones and pharmaceutical compositions containing them
NZ216438A (en) Steroid-pyrazoles and pharmaceutical compositions
IL78642A0 (en) Dihydropyridines and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20031103

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)